세계의 이종이식 시장 보고서(2025년)

Xenotransplantation involves transplanting nonhuman animal cells, tissues, or organs into humans, or vice versa, including ex vivo contact between human and nonhuman animal tissues.

The main products in the field of xenotransplantation include organ preservation solutions, transplant diagnostics, and tissue products. Organ preservation solutions are designed to reduce ischemic and hypoxic damage during cold storage, thereby enhancing graft survival. This category encompasses techniques such as machine perfusion, in situ core cooling, and various organ preservation fluids. Treatments related to xenotransplantation involve the use of analgesics, immunosuppressants, and other therapeutic approaches applicable to organs such as the heart and kidney. End-users of xenotransplantation products include hospitals, transplant centers, and other relevant institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The xenotransplantation market research report is one of a series of new reports from The Business Research Company that provides xenotransplantation market statistics, including xenotransplantation industry global market size, regional shares, competitors with a xenotransplantation market share, detailed xenotransplantation market segments, market trends and opportunities, and any further data you may need to thrive in the xenotransplantation industry. This xenotransplantation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The xenotransplantation market size has grown strongly in recent years. It will grow from $14.68 billion in 2024 to $15.77 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to growing demand for organ transplant, animal breeding, clinical trials, developments in regulatory approvals, surgical techniques.

The xenotransplantation market size is expected to see strong growth in the next few years. It will grow to $21.8 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to global healthcare infrastructure, public funding, telemedicine, public perception and acceptance, use of AI. Major trends in the forecast period include personalized xenotransplantation, multi-organ transplants, integration with precision medicine, long-term monitoring solutions, use of blockchain.

The forecast of 8.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to genetically engineered porcine organs and transplant monitoring equipment imported from Denmark and South Korea, potentially derailing breakthrough therapies and increasing experimental surgery costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising demand for tissue and organ transplantation is expected to propel the growth of the xenotransplantation market. Diseases such as polycystic kidney disease, cystic fibrosis, and heart disorders frequently require organ transplants for many individuals. However, the significant demand for organ transplants has led to a shortage of available organs for transplantation. Xenotransplantation offers a potential solution to this issue by using nonhuman organs as substitutes for human organs. For instance, in January 2023, the United Network for Organ Sharing, a US-based non-profit scientific and educational organization, reported that the United States performed 42,887 organ transplants in 2022, reflecting a 3.7 percent increase from 2021 and establishing a new annual record. Therefore, the growing demand for tissue and organ transplantation is anticipated to be a key driver of the xenotransplantation market's growth.

The rise in surgical procedures is anticipated to drive the expansion of the xenotransplantation market in the future. These procedures involve manual or instrumental methods to diagnose or address medical conditions. Xenotransplantation, which involves transplanting organs, tissues, or cells from one species to another, holds significant promise for revolutionizing the realm of surgery. Due to the scarcity of human organs available for transplantation, xenotransplantation has emerged as an alternative solution. For instance, in April 2022, as reported by The Aesthetic Society, a premier organization dedicated to aesthetic plastic surgery, surgical procedures surged by 54%, while non-surgical procedures increased by 44% compared to the previous year. Consequently, the increasing number of surgical procedures is a key driver behind the growth of the xenotransplantation market.

Major companies in the xenotransplantation market are introducing new technologies, such as preservation technology, to enhance the preservation methods and efficiency for delicate organs. Preservation technology encompasses various tools and methodologies used to protect and maintain the integrity of valuable objects, information, or environments over time. For example, in January 2022, XVIVO, a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue, and cell preservation, introduced an innovative technique for efficiently storing and transporting donated hearts. The organ shortage is a significant challenge facing the transplant industry, limiting the number of patients with end-stage heart disease who receive transplant opportunities. This shortage leads to many patients passing away while awaiting a suitable organ. Xenotransplantation, which involves transplanting organs between different species, is one potential approach to address this severe scarcity. A recent groundbreaking study utilizing XVIVO's heart preservation technology achieved long-term survival following the xenotransplantation of gene-modified pig hearts into primates. This advancement holds promise for addressing the organ shortage crisis and improving transplant outcomes.

Major companies in the xenotransplantation market are prioritizing strategic partnerships to deliver reliable services to their customers. A strategic partnership is an arrangement between two or more companies or organizations that collaborate to achieve their respective goals. For example, in April 2023, Karius, a US-based company and a global leader in liquid biopsy for infectious diseases, formed a partnership with eGenesis, Inc., a US-based biotechnology company at the forefront of xenotransplantation research. The purpose of this collaboration is to develop human-compatible organs and cells for treating organ failure. By leveraging Karius's platform, which is capable of identifying and measuring diseases present in organ donors from pigs, the partnership aims to create a more comprehensive testing platform for microbial cell-free DNA. This platform will serve as the basis for surveillance and monitoring before and after transplantation, ultimately contributing to the alleviation of organ shortages and accelerating the availability of safe xenotransplantation.

In October 2023, United Therapeutics Corporation, a US-based biotechnology company, acquired Miromatrix Medical for $91 million. This strategic acquisition is intended to expand United Therapeutics' existing organ production initiatives, which include xenotransplantation, 3-D bioprinting, x-vivo lung perfusion, and regenerative medicine techniques. Miromatrix Medical, based in the US, is a development-stage company known for its fully implantable manufactured kidney product.

Major companies operating in the xenotransplantation market include Novartis AG, Astellas Pharma, United Therapeutics, Preservation Solutions, OrganOX Limited, Talaris Therapeutics, TransMedic Inc., Sernova Corp, Nova Lung, Recombinetics, Tissue Regenix, TissueGene, SAB Biotherapeutics, eGenesis, Revivicor, Organ Recovery Systems, CRISPR Therapeutics, Qihan Biotech, Sino-Clone Organ Biotechnology, Xenothera, Lung Biotechnology.

North America was the largest region in the xenotransplantation market in 2024. The regions covered in the xenotransplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the xenotransplantation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The xenotransplantation market includes revenues earned by entities by providing transplantation and diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Xenotransplantation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on xenotransplantation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for xenotransplantation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The xenotransplantation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Products: Organ Preservation Solutions; Transplant Diagnostics; Tissue Products
• 2) By Treatment: Analgesic; Immunosuppressant; Other Treatments
• 3) By Applications: Heart; Kidney; Other Organs
• 4) By End-Users: Hospitals; Transplant Centers; Other End-Users
• Subsegments:
• 1) By Organ Preservation Solutions: Hypothermic Preservation Solutions; Normothermic Preservation Solutions; Organ Storage Solutions
• 2) By Transplant Diagnostics: Pre-Transplant Compatibility Testing; Post-Transplant Monitoring; Molecular Diagnostics
• 3) By Tissue Products: Xenograft Tissue Products; Tissue Engineered Products; Biological Scaffolds
• Companies Mentioned: Novartis AG; Astellas Pharma; United Therapeutics; Preservation Solutions; OrganOX Limited; Talaris Therapeutics; TransMedic Inc.; Sernova Corp; Nova Lung; Recombinetics; Tissue Regenix; TissueGene; SAB Biotherapeutics; eGenesis; Revivicor; Organ Recovery Systems; CRISPR Therapeutics; Qihan Biotech; Sino-Clone Organ Biotechnology; Xenothera; Lung Biotechnology.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Xenotransplantation Market Characteristics

3. Xenotransplantation Market Trends And Strategies

4. Xenotransplantation Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Xenotransplantation Growth Analysis And Strategic Analysis Framework

• 5.1. Global Xenotransplantation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Xenotransplantation Market Growth Rate Analysis
• 5.4. Global Xenotransplantation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Xenotransplantation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Xenotransplantation Total Addressable Market (TAM)

6. Xenotransplantation Market Segmentation

• 6.1. Global Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Organ Preservation Solutions
• Transplant Diagnostics
• Tissue Products
• 6.2. Global Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesic
• Immunosuppressant
• Other Treatments
• 6.3. Global Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Heart
• Kidney
• Other Organs
• 6.4. Global Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Transplant Centers
• Other End-Users
• 6.5. Global Xenotransplantation Market, Sub-Segmentation Of Organ Preservation Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypothermic Preservation Solutions
• Normothermic Preservation Solutions
• Organ Storage Solutions
• 6.6. Global Xenotransplantation Market, Sub-Segmentation Of Transplant Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Transplant Compatibility Testing
• Post-Transplant Monitoring
• Molecular Diagnostics
• 6.7. Global Xenotransplantation Market, Sub-Segmentation Of Tissue Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Xenograft Tissue Products
• Tissue Engineered Products
• Biological Scaffolds

7. Xenotransplantation Market Regional And Country Analysis

• 7.1. Global Xenotransplantation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Xenotransplantation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Xenotransplantation Market

• 8.1. Asia-Pacific Xenotransplantation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Xenotransplantation Market

• 9.1. China Xenotransplantation Market Overview
• 9.2. China Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Xenotransplantation Market

• 10.1. India Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Xenotransplantation Market

• 11.1. Japan Xenotransplantation Market Overview
• 11.2. Japan Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Xenotransplantation Market

• 12.1. Australia Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Xenotransplantation Market

• 13.1. Indonesia Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Xenotransplantation Market

• 14.1. South Korea Xenotransplantation Market Overview
• 14.2. South Korea Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Xenotransplantation Market

• 15.1. Western Europe Xenotransplantation Market Overview
• 15.2. Western Europe Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Xenotransplantation Market

• 16.1. UK Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Xenotransplantation Market

• 17.1. Germany Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Xenotransplantation Market

• 18.1. France Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Xenotransplantation Market

• 19.1. Italy Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Xenotransplantation Market

• 20.1. Spain Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Xenotransplantation Market

• 21.1. Eastern Europe Xenotransplantation Market Overview
• 21.2. Eastern Europe Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Xenotransplantation Market

• 22.1. Russia Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Xenotransplantation Market

• 23.1. North America Xenotransplantation Market Overview
• 23.2. North America Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Xenotransplantation Market

• 24.1. USA Xenotransplantation Market Overview
• 24.2. USA Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Xenotransplantation Market

• 25.1. Canada Xenotransplantation Market Overview
• 25.2. Canada Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Xenotransplantation Market

• 26.1. South America Xenotransplantation Market Overview
• 26.2. South America Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Xenotransplantation Market

• 27.1. Brazil Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Xenotransplantation Market

• 28.1. Middle East Xenotransplantation Market Overview
• 28.2. Middle East Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Xenotransplantation Market

• 29.1. Africa Xenotransplantation Market Overview
• 29.2. Africa Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Xenotransplantation Market Competitive Landscape And Company Profiles

• 30.1. Xenotransplantation Market Competitive Landscape
• 30.2. Xenotransplantation Market Company Profiles
  • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Astellas Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. United Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Preservation Solutions Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. OrganOX Limited Overview, Products and Services, Strategy and Financial Analysis

31. Xenotransplantation Market Other Major And Innovative Companies

• 31.1. Talaris Therapeutics
• 31.2. TransMedic Inc.
• 31.3. Sernova Corp
• 31.4. Nova Lung
• 31.5. Recombinetics
• 31.6. Tissue Regenix
• 31.7. TissueGene
• 31.8. SAB Biotherapeutics
• 31.9. eGenesis
• 31.10. Revivicor
• 31.11. Organ Recovery Systems
• 31.12. CRISPR Therapeutics
• 31.13. Qihan Biotech
• 31.14. Sino-Clone Organ Biotechnology
• 31.15. Xenothera

32. Global Xenotransplantation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Xenotransplantation Market

34. Recent Developments In The Xenotransplantation Market

35. Xenotransplantation Market High Potential Countries, Segments and Strategies

• 35.1 Xenotransplantation Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Xenotransplantation Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Xenotransplantation Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer